Dr. Kaouthar Lbiati
Equibles does not estimate personal net worth.
Get an email with a short summary when Hepion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get HEPA alertsAbout Dr. Kaouthar Lbiati
Dr. Kaouthar Lbiati is recorded as CEO at Hepion Pharmaceuticals, Inc. (HEPA) since January 8, 2026. Hepion Pharmaceuticals, Inc. reported in an 8-K filed April 14, 2026 that Dr. Kaouthar Lbiati resigned as director, effective April 13, 2026. Hepion Pharmaceuticals, Inc. reported in an 8-K filed January 15, 2026 that Dr. Kaouthar Lbiati was appointed Chief Executive Officer, effective January 8, 2026. Hepion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hepion Pharmaceuticals, Inc. includes Gary Stetz (CEO, CFO and Board Member), John Cavan (CEO and CFO), Kaouthar Lbiati (CEO and Board Member) and 7 others.
“On April 13, 2026, Dr. Lbiati resigned as a director of the Company.”
“On January 13, 2026, the Board of Directors of Hepion Pharmaceuticals, Inc., a Delaware corporation (the "Company"), approved the employment agreement (the "Lbiati Employment Agreement") of Dr. Kaouthar Lbiati as Chief Executive Officer (the "Executive"), effective as of January 8, 2026 (the "Effective Date").”
Affiliation history
-
Current
2026-01-08–present
Company network
Leadership on record at Hepion Pharmaceuticals, Inc.
- Gary Stetz CEO, CFO, Board Member
- John Cavan CEO, CFO
- Kaouthar Lbiati CEO, Board Member
- Sireesh Appajosyula CEO, Board Member
- John Brancaccio Chairman, CFO
- Vincent LoPriore Chairman
- Chase LoPriore Board Member
- Danina Fisher Board Member
- Gary S. Stetz, II Board Member
- James Liddy Board Member